Abstract
Background
Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative disease affecting the motor nervous system and currently lacking effective means of treatment. The focus of ALS treatment therefore lies in palliative treatment from a multidisciplinary team. Published findings regarding affective components and patients’ perceived quality-of-life (QoL) as well as comparative reports of family members/caregivers remain equivocal.
Methods
In this study, 41 ALS patients and their relatives were enrolled in a study employing the 12-item ALS-Depression-Inventory (ADI-12) and the Munich quality-of-life dimensions list (MLDL). The ALS-functional rating scale (ALSFRS-R) was used to evaluate physical disabilities.
Results
The ADI-12 depression scale data identified nine patients with depressive disorders; the patients had satisfactory QoL outcomes on the MLDL. The results did not differ significantly between ALS patients and their relatives.
Conclusions
Thus, in agreement with other studies, QoL and emerging depression do not automatically coincide with patients’ physical impairments of the patients. This “well-being paradox” is currently not well understood, and further studies are needed to optimize the treatment of patients through the course of disease progression.
Similar content being viewed by others
References
Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: A theoretical model. Social Science and Medicine, 48(11), 1507–1515.
Yoshida, S., Mulder, D. W., Kurland, L. T., Chu, C. P., & Okazaki, H. (1986). Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology, 5(2), 61–70.
Kondo, K. (1995). Epidemiology of motor neuron disease. In P. N. Leigh & M. Swash (Eds.), Motor Neuron Disease Biology and Management (pp. 19–33). London: Springer Verlag.
Kristjanson, L. J., Toye, C., & Dawson, S. (2003). New dimensions in palliative care: A palliative approach to neurodegenerative diseases and final illness in older people. Medical Journal of Australia, 179(6 Suppl), S41–S43.
Kübler, A., Winter, S., Kaiser, J., Birbaumer, N., & Hautzinger, M. (2005). Das ALS-Depressionsinventar (ADI): Ein Fragebogen zur Messung von Depression bei degenerativen neurologischen Erkrankungen (Amyotrophe Lateralsklerose). Zeitschrift für Klinische Psychologie und Psychotherapie, 34(1), 19–26.
Rabkin, J. G., Albert, S. M., Del Bene, M. L., O’Sullivan, I., Tider, T., Rowland, L. P., et al. (2005). Prevalence of depressive disorders and change over time in late-stage ALS. Neurology, 65(1), 62–67.
Trail, M., Nelson, N., Van, J. N., Appel, S. H., & Lai, E. C. (2003). A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. Journal of the Neurological Sciences, 209, 79–85.
Kurt, A., Nijboer, F., Matuz, T., & Kübler, A. (2007). Depression and anxiety in individuals with amyotrophic lateral sclerosis. CNS Drugs, 21(4), 270–291.
Gauthier, A., Vignola, A., Calvo, A., Cavallo, E., Moglia, C., Sellitti, L., et al. (2007). A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology, 68(12), 923–926.
Lule, D., Häcker, S., Ludolph, A. C., Bierbaumer, N., & Kübler, A. (2008). Depression und Lebensqualität bei Patienten mit amyotropher Lateralsklerose. Deutsches Ärzteblatt, 105(23), 397–403.
Kaub-Wittemer, D., Steinbuchel, N., Wasner, M., Laier-Groeneveld, G., & Borasio, G. D. (2003). Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. Journal of Pain and Symptom Management, 26(4), 890–896.
Lo Coco, G., Lo Coco, D., Cicero, V., Oliveri, A., Lo Verso, G., Piccoli, F., et al. (2005). Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers. Journal of the Neurological Sciences, 238(1–2), 11–17.
Goldstein, L. H., Atkins, L., & Leigh, P. N. (2002). Correlates of quality of life in people with motor neuron disease (MND). Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 3(3), 123–129.
Robbins, R. A., Simmons, Z., Bremer, B. A., Walsh, S. M., & Fischer, S. (2001). Quality of life in ALS is maintained as physical function decline. Neurology, 56, 442–444.
Chio, A., Gauthier, A., Calvo, A., Ghiglione, P., & Mutani, R. (2005). Caregiver burden and patients’ perception of being a burden in ALS. Neurology, 64(10), 1780–1782.
Ganzini, L., Johnston, W. S., & Hoffman, W. F. (1999). Correlates of suffering in amyotrophic lateral sclerosis. Neurology, 52(7), 1434–1440.
Kübler, A., Winter, S., Ludolph, A. C., Hautzinger, M., & Bierbaumer, N. (2005). Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabilitation Neural Repair, 19, 182–193.
Adelman, E. E., Albert, S. M., Rabkin, J. G., Del Bene, M. L., Tider, T., & O’Sullivan, I. (2004). Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology, 62(10), 1766–1770.
Brooks, B. R. (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. Journal of the Neurological Sciences, 124(Suppl), 96–107.
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., et al. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences, 169(1–2), 13–21.
Von Steinbüchel, N., Bullinger, M., & Kirchberger, I. (1999). Die Münchner Lebensqualitäts-Dimensionen Liste (MLDL): Entwicklung und Prüfung eines Verfahrens zur krankheitsübergreifenden Erfassung von Lebensqualität. Zeitschrift für medizinische Psychologie, 3, 99–112.
Hautzinger, M. (1998). Depression. Göttingen: Hogrefe.
Ho, A. (2008). Relational autonomy or undue pressure? Family’s role in medical decision-making. Scandinavian Journal of Caring Sciences, 22(1), 128–135.
Kim, S. Y., Kim, H. M., Langa, K. M., Karlawish, J. H., Knopman, D. S., & Appelbaum, P. S. (2009). Surrogate consent for dementia research: A national survey of older Americans. Neurology, 72(2), 149–155.
Ruhnke, G. W., Wilson, S. R., Akamatsu, T., Kinoue, T., Takashima, Y., Goldstein, M. K., et al. (2000). Ethical decision making and patient autonomy: A comparison of physicians and patients in Japan and the United States. Chest, 118(4), 1172–1182.
McLeod, J. E., & Clarke, D. M. (2007). A review of psychosocial aspects of motor neurone disease. Journal of the Neurological Sciences, 258(1–2), 4–10.
Wicks, P., Abrahams, S., Masi, D., Hejda-Forde, S., Leigh, P. N., & Goldstein, L. H. (2007). Prevalence of depression in a 12-month consecutive sample of patients with ALS. European Journal of Neurology, 14(9), 993–1001.
Kiebert, G. M., Green, C., Murphy, C., Mitchell, J. D., O’Brien, M., Burrell, A., et al. (2001). Patients’ health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191(1–2), 87–93.
Herschbach, P. (2002). The “Well-being paradox” in quality-of-life research. Psychotherapie, Psychosomatik, Medizinische Psychologie, 52(3–4), 141–150.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grehl, T., Rupp, M., Budde, P. et al. Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ?. Qual Life Res 20, 569–574 (2011). https://doi.org/10.1007/s11136-010-9781-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-010-9781-7